Abstract
Systemic mastocytosis is a rare and occasionally aggressive condition that raises major diagnostic challenges. We report a case in a 72-year-old patient in whom the diagnosis of malignant mastocytosis required two bone marrow smears and three bone marrow biopsies examined using specific staining techniques. Despite interferon therapy, a mast-cell sarcoma of the sternum developed 1 year after symptom onset, followed 1 year later by acute myeloblastic leukemia, which was rapidly fatal.
MeSH terms
-
Aged
-
Alendronate / therapeutic use
-
Bone Marrow Cells / enzymology
-
Bone Marrow Cells / pathology
-
Fatal Outcome
-
Female
-
Humans
-
Interferon-alpha / therapeutic use
-
Leukemia, Myeloid, Acute / pathology
-
Mast Cells / enzymology
-
Mast Cells / pathology
-
Mast-Cell Sarcoma / pathology
-
Mastocytosis, Systemic / complications
-
Mastocytosis, Systemic / pathology*
-
Mastocytosis, Systemic / therapy
-
Neoplasms, Multiple Primary
-
Osteoporosis, Postmenopausal / drug therapy
-
Prednisone / therapeutic use
-
Serine Endopeptidases / metabolism
-
Tryptases
Substances
-
Interferon-alpha
-
Serine Endopeptidases
-
Tryptases
-
Prednisone
-
Alendronate